Company profile
Aclaris Therapeutics, Inc. Insider Trading
ACRSEvery SEC Form 4 insider trading filing for Aclaris Therapeutics, Inc. (ACRS) since April 2023 — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Exchange
- Nasdaq
- Sector
- Pharmaceutical Preparations
- CIK
- 0001557746
- Filings
- 114
- Insiders
- 18
- Last filing
- 2026-08-01
Activity summary
No insider transactions in the last 30 days. The most recent was on August 1, 2026, when Roland Wilhelm Kolbeck bought 36,375 shares. 114 filings from 18 insiders are on record below.
Three year balance
Buy and sell value by quarter, Q4 23 to Q3 26. Aclaris Therapeutics, Inc. insiders are net buyers across the period shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $4.0M.
90 day insight
Over the last 90 days, Aclaris Therapeutics, Inc. insiders bought $0 (2 transactions) and sold $64K (1 transaction).
- Most active insider: Roland Wilhelm Kolbeck with 3 transactions totaling $64K.
- Largest single sale: $64K by Roland Wilhelm Kolbeck on Aug 1, 2026.
Activity skews bullish — buys outpace sales.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 1, 2026 | Roland Wilhelm Kolbeck | ACRS | Option Exercise | 36,375 | — | — |
| Aug 1, 2026 | Roland Wilhelm Kolbeck | ACRS | Tax Withholding | 12,385 | $5.20 | $64K |
| Aug 1, 2026 | Roland Wilhelm Kolbeck | ACRS | Option Exercise | 36,375 | — | — |
| Jun 5, 2026 | William D. Humphries | ACRS | Option Exercise | 11,580 | — | — |
| Jun 5, 2026 | William D. Humphries | ACRS | Option Exercise | 11,580 | — | — |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=ACRS" \
-H "X-Api-Key: $KEY"Top insiders
By total value filed.
Institutional Ownership
Top 13F-HR holders of Aclaris Therapeutics, Inc. as of 2026-06-30
Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →